Autoimmune antiphospholipid antibodies: what is their true target?
Pengo
V
V
Dept. of Cardiology, University of Padua School of Medicine, Italy.
Biasiolo
A
A
Fior
M G
MG
D017152:Antibodies, Antiphospholipid / Q000276:immunology*; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D001324:Autoantigens / Q000276:immunology*; D004198:Disease Susceptibility / Q000276:immunology; D005260:Female; D006023:Glycoproteins / Q000276:immunology* / Q000502:physiology; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D008875:Middle Aged; D010743:Phospholipids / Q000276:immunology*; D011485:Protein Binding; D013923:Thromboembolism / Q000209:etiology; D053482:beta 2-Glycoprotein I
D017152:Antibodies, Antiphospholipid; D001324:Autoantigens; D006023:Glycoproteins; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D010743:Phospholipids; D053482:beta 2-Glycoprotein I